Innovative approaches for personalized cardiovascular prevention
Official title: Feasibility of InnovaTive Approaches for Personalized Cardiovascular PREVention: Randomized Controlled Pilot Trial and Multidisciplinary Evaluation for National Health Service Implementation
Run by Catholic University of the Sacred Heart · NCT06911294 · Data updated 2026-11-12
This study is testing if using genetic information and smartwatches can help people make healthier choices to prevent heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 69 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Catholic University of the Sacred Heart Academic / other |
| Locations | 7 sites (Rome, Italy and 6 other locations) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | February 10, 2026 |
| Study ends | September 10, 2026 |
| Registry record updated | August 5, 2025 |
| Trial ID | NCT06911294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40-69 with a 10-year cardiovascular risk score between 2.5% and 10% and a diagnosis of metabolic syndrome.
✕Probably not a fit
Patients with diabetes, familial hypercholesterolemia, or a history of cardiovascular events may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the feasibility of using innovative methods, such as Polygenic Risk Scores and health smartwatches, for personalized primary prevention of cardiovascular diseases. Participants will be randomized into four groups: standard care, genetic testing, digital intervention with a wearable device, or a combination of both. The study will assess the effectiveness of these interventions in promoting healthier lifestyle behaviors in a realistic setting, specifically within general practitioners' offices. The trial will last for 12 months, with key assessments at baseline, one month, six months, and twelve months.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective prevention strategies for coronary heart disease.
How similar studies have gone: Other studies have shown promise in using genetic risk scores and digital interventions for cardiovascular prevention, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 40-69 years; * 10 year cardiovascular risk score SCORE2 between 2.5% and 10%. * Diagnosis of metabolic syndrome according to the American Heart Association criteria , defined as the presence of three or more of the following: * Central or abdominal obesity, measured by waist circumference (greater than 40 inches - 102 cm in men and 35 inches - 89 cm in women). * Elevated triglycerides: levels equal to or greater than 150 mg/dL or use of medication for hypertriglyceridemia. * Low HDL cholesterol levels (less than 40 mg/dL in men and less than 50 mg/dL in women) or use of cholesterol-lowering medication. * Elevated blood pressure: systolic ≥130 mmHg or diastolic ≥85 mmHg, or use of antihypertensive medication. * Elevated fasting blood glucose: ≥100 mg/dL or use of glucose-lowering medication. Exclusion Criteria: * Diabetes: * Familial hypercholesterolemia; * Previous cardiovascular events.
Where it's running
-
Studio Antonaci
Rome, Italy, Italy Recruiting -
Studio Colletti
Rome, Italy Recruiting -
Studio Maggiori
Rome, Italy Recruiting -
Studio Mammucari
Rome, Italy Recruiting -
Studio Marra
Rome, Italy Recruiting -
Studio Paoletti
Rome, Italy Recruiting
Show 1 more location
-
Studio Pasca
Rome, Italy Recruiting
Study contacts
- Study coordinator: Roberta Pastorino
- Email: roberta.pastorino@unicatt.it
- Phone: +393495624174
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Prospective cardiac surgery cohort to improve perioperative care
A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.
-
Mazdutide and coronary plaque in people with coronary artery disease and overweight or obesity
This study tests whether mazdutide can slow or reduce coronary plaque build-up in adults with coronary artery disease who are overweight or obese.
-
Understanding risk factors for cognitive problems in people with coronary heart disease
In people with coronary heart disease, this study tests how metabolic factors and imaging features relate to cognitive impairment.
-
Yiyang Huoluo Decoction for coronary heart disease with atherosclerosis in older adults
This study will test whether adding the Yiyang Huoluo herbal decoction to standard heart care helps people aged 50–75 with coronary heart disease and atherosclerosis.
-
Glycocalyx and oxidative stress in blood vessel lining during coronary bypass surgery
This project will see if changes in the endothelial glycocalyx and oxidative stress markers relate to microvascular function and outcomes in adults having elective coronary artery bypass grafting.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.